Leandro Pinheiro Safatle, executive secretary of the Brazilian Drug Market Regulation Chamber (CMED) explains why pharmaceuticals was the only sector to have resisted the country’s recent recession, the role that CMED has played in stabilizing the price evolution of medicines in Brazil, and the importance of increasing the regulatory framework’s transparency.
Can you introduce the Brazilian Drug Market Regulation Chamber’s (CMED) mission and importance within Brazil’s Healthcare system?
"Currently CMED's main objective is to move forward with the regulatory apparatus for the new challenges and promote transparency."
